[1] |
Feng X L, Zhou W, Li H, et al. The DLC-1-29A/T polymorphism is not associated with nasopharyngeal carcinoma risk in Chinese population[J]. Genet Test, 2008, 12(3): 345-9.
|
[2] |
Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors[J]. Semin Cancer Biol, 2012, 22(2): 107-16.
|
[3] |
Li XH, Meng YL,Zhao LJ,et al. Epstein-barr virus antibodies response for zhuang npc patients of different ages[J].Zhong Liu Fang Zhi Yan JIu,2013,40(4):377-80.[ 李晓华, 蒙以良, 赵丽娟, 等. EB病毒抗体检测在不同年龄壮族鼻咽癌患者中的应用[J]. 肿瘤防治研究, 2013, 40(4): 377-80.]
|
[4] |
Lin JC, Jan JS, Hsu CY, et al. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates[J]. Br J Cancer, 2003, 88(2): 187-94.
|
[5] |
Palazzi M, Orlandi E, Bossi P, et al. Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience[J]. Int J Radiat Oncol Biol Phys, 20 09, 74(3): 774-80.
|
[6] |
Jiang W, Zhang C, Luo Y, et al. Correlation between nasopharyngeal carcinoma and the expression of VEGF protein in nasopharyngeal carcinoma[J]. Xian Dai Zhong Liu Yi Xue, 2010,18(12):2354-7. [蒋 伟, 张成, 罗元, 等.VEGF蛋白表达与鼻咽癌临床特征相关性研 究[J] 现代肿瘤医学, 2010, 18(12): 2354-7.
|
[7] |
Cosín R, Gilabert-Estellés J, Ramón LA, et al. Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression[J]. Fertil Steril, 2009, 92(4): 1214-20.
|
[8] |
Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production[J]. Cytokine, 2000, 12(8): 1232-5.
|
[9] |
Ku KT, Wan L, Peng HC, et al. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer[J]. Oral Oncol, 2005, 41(5): 497-502.
|
[10] |
Lin CC, Wu HC, Tsai FJ, et al. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer[J]. Urology, 2003, 62(2): 374-7.
|
[11] |
Onen IH, Konac E, Eroglu M, et al. No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population[J]. Mol Biol Rep, 2008, 35(1): 17-22.
|
[12] |
Chen MH, Tzeng CH, Chen PM, et al. VEGF-460T/C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma[J]. Pharmacogenomics J, 2010, 11(3): 227-36.
|
[13] |
Masago K, Fujita S, Kim YH,et al. Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage nonsmall- cell lung cancer[J]. Cancer Sci, 2009, 100(10): 1917-22.
|
[14] |
Gao F, Zhou XT, Zhang ZF, et al. Relationship between single nucleotide polymorphisms of -460T/C in VEGF gene and the susceptibility of lung cancer in Hebei province[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2012, 19(8):575-8.[高峰, 周雪涛, 张 泽峰, 等. VEGF 基因-460T/C 单核苷酸多态性与河北地区汉 族人群肺癌发病风险相关性分析[J]. 中华肿瘤防治杂志, 2012, 19 (8):575-8.]
|
[15] |
Jia A, Gong J, Li YC. Relationship between vascular endothelial growth factor gene-460C/T polymorphism and noncardiac gastric cancer[J]. Wei Chang Bing Xue He Gan Bing Xue Za Zhi, 2012, 21 (5): 399-402.[贾皑, 龚均, 厉英超. 血管内皮生长因子-460C/ T 基因多态性与非贲门胃癌的关系[J].胃肠病学和肝病学杂志, 20 12, 21(5): 399-402.]
|